Document is current
Any future updates will be listed below
-
Authors
Wang, Yen-Feng
-
Funding
Funding for this research was provided by:
National Science and Technology Council (109-2314-B-075 -054, 110-2314-B-075 -041 -MY3, and 113-2314-B-075 -049 -MY3)
Taipei Veterans General Hospital (V108C-092, V109C-096, V110C-111, V111C-161, V112C-078, V113C-123, V114C-096, and V112D67-003-MY3)
- License Information
-
More Information
Article History
Received: 16 January 2025
Accepted: 14 February 2025
First Online: 1 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: YFW has received personal fees as an advisor or a speaker from Allergan/AbbVie, Boehringer Ingelheim, Chugai, Daiichi-Sankyo, Eli Lilly, Hava Bio-Pharma, Lundbeck, Novartis, Orient EuroPharma, Pfizer, Sanofi, Teva, UCB, and Viatris. He has received research grants from the Taiwan National Science and Technology Council, and Taipei Veterans General Hospital.
